September 1, 2022
1 min read

BioNTech gets US nod for Omicron booster

The companies noted that they will supply the original and bivalent vaccines under their existing supply agreement with the US government…reports Asian Lite news

Germany’s BioNTech SE and its US partner Pfizer Inc. have gained emergency US approval for their booster vaccination for the Omicron variant of the coronavirus in the US.

The US Food and Drug Administration (FDA) granted emergency use authorisation for a 30-microgram booster dose of the Pfizer-BioNTech Covid-19 vaccine, bivalent and Omicron BA.4/BA.5, for individuals aged 12 years and above, Pfizer and BioNTech said in a statement on Wednesday.

The companies noted that they will supply the original and bivalent vaccines under their existing supply agreement with the US government, dpa news agency reported.

Booster vaccinations for individuals aged 12 years and above are anticipated to start subject to and after the Centers for Disease Control and Prevention (CDC) endorse a potential recommendation by the Advisory Committee on Immunisation Practices.

Pfizer and BioNTech said that they will begin shipping bivalent doses as directed by the US government.

Eligible US residents will continue to receive the vaccine for free, consistent with the US government’s commitment to free access to Covid-19 vaccines.

The companies stated that an application for an Omicron-adapted bivalent vaccine for children aged between 5-11 years is planned for submission to FDA in early October.

The companies are working with the FDA to prepare an application for an Omicron-adapted bivalent vaccine in children aged between six months to 4 years.

ALSO READ: Iran demands ‘stronger’ US guarantees for n-deal revival

Previous Story

Iran demands ‘stronger’ US guarantees for n-deal revival

Next Story

Sri Lanka qualify for Super Four with thrilling two wicket win

Latest from -Top News

MIND Diet Shows Short-Term Gains for Cognition

The study enrolled 604 participants who were overweight, had a suboptimal diet, and a family history of Alzheimer’s disease The MIND diet, known for its emphasis on brain-healthy foods like whole grains,

Indian-American Takes Office as Head of NIH

Born in Kolkata, India, Dr. Bhattacharya earned both his BA and MA degrees in economics from Stanford University, followed by a doctorate in medicine and a PhD in economics from the same
Go toTop

Don't Miss

Biden: US has its responses ready if Putin uses nukes

During an interview, Biden said that US has gamed out

Low expectations from Trump presidency in Africa 

  Observers say African countries — once described by Trump